# MFAP2

## Overview
The MFAP2 gene encodes microfibril-associated glycoprotein 2 (MAGP2), a protein integral to the extracellular matrix (ECM) and involved in the structural organization and function of microfibrils. MAGP2 is characterized by its hydrophilic nature and distinct domain structure, which includes an acidic, cysteine-free amino-terminal half and a basic, cysteine-rich carboxyl-terminal half, facilitating its role in forming intermolecular disulfide bonds (Gibson1996Further). This protein is crucial for maintaining tissue stability and elasticity, participating in the assembly of microfibrils and elastin production, and serving as a binding site for bioactive molecules that mediate signal transmission from the ECM to cells (Xu2022The). MAGP2's interactions with growth factors, particularly the transforming growth factor-beta (TGF-β) superfamily, underscore its regulatory role in cellular processes and ECM dynamics (Zhu2020Molecular; Xu2022The). The gene's expression is notably significant in osteoblasts and ocular tissues, with implications for bone metabolism and potential links to various cancers and connective tissue disorders (Zhu2020Molecular; Zhang2021Upregulation).

## Structure
The MFAP2 gene encodes the microfibril-associated glycoprotein 2 (MAGP2), which is a component of the extracellular matrix. The primary structure of MAGP2 includes a 510-bp coding region, resulting in a mature protein of 152 amino acids. It features a putative signal peptide and is rich in serine and threonine residues. MAGP2 contains an RGD integrin-binding motif and a consensus sequence for N-glycosylation, which are absent in its paralog, MAGP1 (Gibson1996Further).

MAGP2 is a hydrophilic protein with two distinct domains: an acidic, cysteine-free amino-terminal half and a basic, cysteine-rich carboxyl-terminal half. The carboxyl-terminal domain contains eight cysteine residues, which are involved in forming intermolecular disulfide bonds, suggesting a structural role in microfibrils (Gibson1996Further). The protein's isoelectric point is relatively neutral (pI 6.6) (Gibson1996Further).

MAGP2 does not associate with the extracellular matrix due to a single amino acid difference compared to MAGP1, which affects its matrix-binding domain (Segade2002Identification). The protein undergoes post-translational modifications, including glycosylation, which may contribute to its observed size on SDS-PAGE (Gibson1996Further).

## Function
Microfibrillar-associated protein 2 (MFAP2) is a component of the extracellular matrix (ECM) that plays a significant role in maintaining tissue stability and elasticity. It is involved in the assembly of microfibrils and the production of elastin, which are crucial for the structural integrity and function of tissues (Xu2022The). MFAP2 serves as a reservoir and binding site for bioactive molecules, facilitating signal transmission from the ECM to cells. This signaling regulates various cellular functions such as survival, growth, migration, differentiation, and immunity, which are essential for maintaining normal homeostasis (Xu2022The).

In healthy human cells, MFAP2 interacts with growth factors, particularly the transforming growth factor-beta (TGF-β) superfamily, influencing TGF-β signaling in the ECM. This interaction has biological consequences, including the regulation of cellular processes through its involvement in ECM dynamics and growth factor signaling (Zhu2020Molecular; Xu2022The). MFAP2 is primarily expressed in osteoblasts and tissues of the eye, such as the lens and ciliary bodies, and plays a significant role in bone metabolism (Zhu2020Molecular). Its deficiency can lead to impaired thermoregulation, adipocyte hypertrophy, and a predisposition to diabetes, linked to elevated TGF-β activity in adipose tissues (Zhu2020Molecular).

## Clinical Significance
Alterations in the expression of the MFAP2 gene have been implicated in various cancers, where it often acts as an oncogene. In hepatocellular carcinoma (HCC), MFAP2 is significantly upregulated and associated with tumor progression, poor prognosis, and shorter overall survival (OS) and disease-free survival (DFS) (Xu2022The; Zhang2021Upregulation). High MFAP2 expression in HCC correlates with increased epithelial-mesenchymal transition (EMT), angiogenesis, and tumor invasiveness (Zhang2021Upregulation).

In gastric cancer, MFAP2 is overexpressed and promotes cancer cell motility through the MFAP2/integrin α5β1/FAK/ERK pathway. This overexpression is linked to poor prognosis and is regulated by the miR-29 family of microRNAs, which are downregulated in gastric cancer (Yao2020MFAP2). MFAP2 is also implicated in breast cancer, where its upregulation is associated with poor prognosis and potential as a diagnostic biomarker (Xu2022The; Yu2024The).

Beyond cancer, MFAP2's role in the extracellular matrix suggests its involvement in connective tissue disorders, although specific diseases related to MFAP2 mutations are not detailed in the provided context. Its interaction with fibrillin 1 is noted in the context of bone resorption and disease progression (Zhang2021Upregulation).

## Interactions
Microfibrillar-associated protein 2 (MFAP2) is involved in various interactions with other proteins, playing a significant role in cancer progression and extracellular matrix (ECM) dynamics. MFAP2 interacts with integrin α5β1, which activates the focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK1/2) pathway, crucial for cell motility and matrix remodeling in gastric cancer (Yao2020MFAP2). This interaction modulates integrin-stimulated FAK activation, affecting cancer cell proliferation and migration (Yao2020MFAP2).

In hepatocellular carcinoma, MFAP2 interacts with fibrillin-1, a key component of microfibrils, contributing to tissue homeostasis and differentiation (Zhu2020MFAP2). MFAP2 is also associated with RAD21, a gene involved in DNA repair and chromosome separation, and is linked to mutant p53 in cancer cells (Zhu2020MFAP2). Additionally, MFAP2's interactions with the transforming growth factor-beta (TGF-b) superfamily are significant, as it acts as an upstream regulator in the TGF-b signaling pathway, influencing proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) phenotype (Xu2022The). These interactions highlight MFAP2's role in tumor invasion, metastasis, and therapy resistance.


## References


[1. (Segade2002Identification) Fernando Segade, Barbara Crippes Trask, Thomas J. Broekelmann, Richard A. Pierce, and Robert P. Mecham. Identification of a matrix-binding domain in magp1 and magp2 and intracellular localization of alternative splice forms. Journal of Biological Chemistry, 277(13):11050–11057, March 2002. URL: http://dx.doi.org/10.1074/jbc.m110347200, doi:10.1074/jbc.m110347200. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m110347200)

[2. (Yao2020MFAP2) Li-wen Yao, Lian-lian Wu, Li-hui Zhang, Wei Zhou, Lu Wu, Ke He, Jia-cai Ren, Yun-chao Deng, Dong-mei Yang, Jing Wang, Gang-gang Mu, Ming Xu, Jie Zhou, Guo-an Xiang, Qian-shan Ding, Yan-ning Yang, and Hong-gang Yu. Mfap2 is overexpressed in gastric cancer and promotes motility via the mfap2/integrin α5β1/fak/erk pathway. Oncogenesis, February 2020. URL: http://dx.doi.org/10.1038/s41389-020-0198-z, doi:10.1038/s41389-020-0198-z. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-020-0198-z)

[3. (Zhu2020MFAP2) Xiang Zhu, Ye Cheng, Fan Wu, Haoyao Sun, Wubin Zheng, Wei Jiang, Junfeng Shi, Shijie Ma, and Hongyong Cao. Mfap2 promotes the proliferation of cancer cells and is associated with a poor prognosis in hepatocellular carcinoma. Technology in Cancer Research &amp; Treatment, January 2020. URL: http://dx.doi.org/10.1177/1533033820977524, doi:10.1177/1533033820977524. This article has 13 citations.](https://doi.org/10.1177/1533033820977524)

[4. (Zhu2020Molecular) Sipin Zhu, Lin Ye, Samuel Bennett, Huazi Xu, Dengwei He, and Jiake Xu. Molecular structure and function of microfibrillar‐associated proteins in skeletal and metabolic disorders and cancers. Journal of Cellular Physiology, 236(1):41–48, June 2020. URL: http://dx.doi.org/10.1002/jcp.29893, doi:10.1002/jcp.29893. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.29893)

[5. (Zhang2021Upregulation) Nu Zhang, Feng Shao, and Weidong Jia. Upregulation of microfibrillar‑associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma. Oncology Letters, August 2021. URL: http://dx.doi.org/10.3892/ol.2021.13000, doi:10.3892/ol.2021.13000. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.13000)

[6. (Gibson1996Further) Mark A. Gibson, George Hatzinikolas, Jaliya S. Kumaratilake, Lawrence B. Sandberg, Jillian K. Nicholl, Grant R. Sutherland, and Edward G. Cleary. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of magp-2 (mp25). Journal of Biological Chemistry, 271(2):1096–1103, January 1996. URL: http://dx.doi.org/10.1074/jbc.271.2.1096, doi:10.1074/jbc.271.2.1096. This article has 117 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.271.2.1096)

[7. (Yu2024The) Jingjing Yu. The use of mfap2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer. American Journal of Translational Research, 16(4):1322–1336, 2024. URL: http://dx.doi.org/10.62347/bldg4505, doi:10.62347/bldg4505. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.62347/bldg4505)

[8. (Xu2022The) Wanzhen Xu, Manfeng Wang, Yang Bai, Yong Chen, Xiaoshan Ma, Zhiqing Yang, Liyan Zhao, and Yunqian Li. The role of microfibrillar‐associated protein 2 in cancer. Frontiers in Oncology, November 2022. URL: http://dx.doi.org/10.3389/fonc.2022.1002036, doi:10.3389/fonc.2022.1002036. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.1002036)